Author:
Germann N.,Urien S.,Rodgers Andrew H.,Ratterree Marion,Struck Robert F.,Waud William R.,Serota David G.,Bastian Gerard,Jursic Branko S.,Morgan Lee Roy
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference13 articles.
1. Bisagni G, Boni C, Mamenti AL, Moretti G, Rondini E, Sassi M, Zadro A, Salvodi L (1998) Ifosfamide bolus followed by five days continuous infusion in extensively pretreated patients with advanced breast cancer: a phase II study. Tumori 84:659?661
2. Blum RH, Edmonson J, Ryan L, Pelletier L (1993) Efficacy of ifosfamide in combination with doxorubicin for the treatment of metastatic soft-tissue sarcoma. The Eastern Cooperative Oncology Group. Cancer Chemother Pharmacol 31:s238?s240
3. Breil S, Martino R, Gilard V, Malet-Martino M, Niemeyer U (2001) Identification of new aqueous chemical degradation products of isophosphoramide mustard. J Pharm Biomed Anal 25:669?678
4. Cosson VF, Fuseau E, Efthymiopoulos C, Bye A (1997) Mixed effect modeling of Sumatriptan pharmacokinetics during drug development: interspecies allometric scaling. J Pharmacokinet Biopharm 25:149?167
5. Hagemeister FB, Donato M (2001) Ifosfamide-based chemotherapy regimens in the treatment of lymphoma: the MD Anderson experience. Eur J Haematol 64:8?13
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献